| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.04 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |